A twisted Long Island man was thrown behind bars after allegedly shooting his sister in the head with a crossbow — a deadly scheme he’d been reportedly plotting since December, according to police.

LAWRENCE, Long Island (WABC) -- A man is charged with attempted murder after police say he shot his sister in the face with a crossbow. Police in Nassau County responded to a home on West Avenue just ...

A 21-year-old Lawrence man has been arrested and charged with attempted murder after he allegedly shot a crossbow at a woman, grazing and cutting her face, Nassau County police said. Officers ...

A new crossbow scope from TenPoint Crossbows can rangefind, record video, and stream to a smartphone. Other innovations include a thermal imager, an improved digital antler measuring tool, and ...

Joe Grantham is a contributor from the UK with a degree in Classical Studies. His love for gaming is only rivaled by a deep passion for medieval history, which often seeps into his articles. With over ...

The gradual loss of near vision that is a natural part of aging can be addressed by glasses, contact lenses, or even surgical procedures. A presbyopia eye drop developed by Tenpoint Therapeutics now ...

Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA approval (PDF) for Yuvezzi, a treatment for presbyopia, a common, age-related ...

U.S. FDA Approves YUVEZZI as the only dual-agent, once daily presbyopia-correcting eye drop Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking ...

LONDON & SEATTLE, January 29, 2026--(BUSINESS WIRE)--Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the ...

Eye redness was not a commonly reported side effect in clinical trials of YUVEZZI. In BRIO I and BRIO II the reports of adverse events of ocular hyperemia (eye redness) were low. 1,2 In BRIO II, the ...

Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced it has secured $235 ...